Literature DB >> 33893322

Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development.

Yanying Huo1,2, Pier Selenica3, Amar H Mahdi1,2,4, Fresia Pareja3, Kelly Kyker-Snowman1,2, Ying Chen1, Rahul Kumar3,5, Arnaud Da Cruz Paula3, Thais Basili3, David N Brown3, Xin Pei6, Nadeem Riaz6, Yongmei Tan7, Yu-Xiu Huang8, Tao Li1,2, Nicola J Barnard9, Jorge S Reis-Filho3, Britta Weigelt10, Bing Xia11,12,13.   

Abstract

Inherited mutations in BRCA1, BRCA2, and PALB2 cause a high risk of breast cancer. Here, we conducted parallel conditional knockout (CKO) of Brca1, Palb2, and Brca2, individually and in combination, along with one copy of Trp53, in the mammary gland of nulliparous female mice. We observed a functional equivalence of the three genes in their basic tumor-suppressive activity, a linear epistasis of Palb2 and Brca2, but complementary roles of Brca1 and Palb2 in mammary tumor suppression, as combined ablation of either Palb2 or Brca2 with Brca1 led to delayed tumor formation. Whole-exome sequencing (WES) revealed both similarities and differences between Brca1 and Palb2 or Brca2 null tumors. Analyses of mouse mammary glands and cultured human cells showed that combined loss of BRCA1 and PALB2 led to high levels of reactive oxygen species (ROS) and increased apoptosis, implicating oxidative stress in the delayed tumor development in Brca1;Palb2 double CKO mice. The functional complementarity between BRCA1 and PALB2/BRCA2 and the role of ROS in tumorigenesis require further investigation.

Entities:  

Year:  2021        PMID: 33893322     DOI: 10.1038/s41523-021-00253-5

Source DB:  PubMed          Journal:  NPJ Breast Cancer        ISSN: 2374-4677


  50 in total

1.  Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.

Authors:  Bing Xia; Qing Sheng; Koji Nakanishi; Akihiro Ohashi; Jianmin Wu; Nicole Christ; Xinggang Liu; Maria Jasin; Fergus J Couch; David M Livingston
Journal:  Mol Cell       Date:  2006-06-23       Impact factor: 17.970

2.  PALB2 is an integral component of the BRCA complex required for homologous recombination repair.

Authors:  Shirley M H Sy; Michael S Y Huen; Junjie Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-15       Impact factor: 11.205

3.  Two decades after BRCA: setting paradigms in personalized cancer care and prevention.

Authors:  Fergus J Couch; Katherine L Nathanson; Kenneth Offit
Journal:  Science       Date:  2014-03-28       Impact factor: 47.728

4.  PALB2 links BRCA1 and BRCA2 in the DNA-damage response.

Authors:  Feng Zhang; Jianglin Ma; Jiaxue Wu; Lin Ye; Hong Cai; Bing Xia; Xiaochun Yu
Journal:  Curr Biol       Date:  2009-03-05       Impact factor: 10.834

5.  Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer.

Authors:  Chun-Chin Chen; Weiran Feng; Pei Xin Lim; Elizabeth M Kass; Maria Jasin
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

6.  Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.

Authors:  Fergus J Couch; Hermela Shimelis; Chunling Hu; Steven N Hart; Eric C Polley; Jie Na; Emily Hallberg; Raymond Moore; Abigail Thomas; Jenna Lilyquist; Bingjian Feng; Rachel McFarland; Tina Pesaran; Robert Huether; Holly LaDuca; Elizabeth C Chao; David E Goldgar; Jill S Dolinsky
Journal:  JAMA Oncol       Date:  2017-09-01       Impact factor: 31.777

7.  Cancer suppression by the chromosome custodians, BRCA1 and BRCA2.

Authors:  Ashok R Venkitaraman
Journal:  Science       Date:  2014-03-28       Impact factor: 47.728

Review 8.  Familial pancreatic cancer: genetic advances.

Authors:  Anil K Rustgi
Journal:  Genes Dev       Date:  2014-01-01       Impact factor: 11.361

9.  Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.

Authors:  Karoline B Kuchenbaecker; John L Hopper; Daniel R Barnes; Kelly-Anne Phillips; Thea M Mooij; Marie-José Roos-Blom; Sarah Jervis; Flora E van Leeuwen; Roger L Milne; Nadine Andrieu; David E Goldgar; Mary Beth Terry; Matti A Rookus; Douglas F Easton; Antonis C Antoniou; Lesley McGuffog; D Gareth Evans; Daniel Barrowdale; Debra Frost; Julian Adlard; Kai-Ren Ong; Louise Izatt; Marc Tischkowitz; Ros Eeles; Rosemarie Davidson; Shirley Hodgson; Steve Ellis; Catherine Nogues; Christine Lasset; Dominique Stoppa-Lyonnet; Jean-Pierre Fricker; Laurence Faivre; Pascaline Berthet; Maartje J Hooning; Lizet E van der Kolk; Carolien M Kets; Muriel A Adank; Esther M John; Wendy K Chung; Irene L Andrulis; Melissa Southey; Mary B Daly; Saundra S Buys; Ana Osorio; Christoph Engel; Karin Kast; Rita K Schmutzler; Trinidad Caldes; Anna Jakubowska; Jacques Simard; Michael L Friedlander; Sue-Anne McLachlan; Eva Machackova; Lenka Foretova; Yen Y Tan; Christian F Singer; Edith Olah; Anne-Marie Gerdes; Brita Arver; Håkan Olsson
Journal:  JAMA       Date:  2017-06-20       Impact factor: 56.272

10.  Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes.

Authors:  Nadeem Riaz; Pedro Blecua; Raymond S Lim; Ronglai Shen; Daniel S Higginson; Nils Weinhold; Larry Norton; Britta Weigelt; Simon N Powell; Jorge S Reis-Filho
Journal:  Nat Commun       Date:  2017-10-11       Impact factor: 14.919

View more
  5 in total

1.  Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegeneration.

Authors:  Yanying Huo; Akshada Sawant; Yongmei Tan; Amar H Mahdi; Tao Li; Hui Ma; Vrushank Bhatt; Run Yan; Jake Coleman; Cheryl F Dreyfus; Jessie Yanxiang Guo; M Maral Mouradian; Eileen White; Bing Xia
Journal:  PLoS Genet       Date:  2022-04-11       Impact factor: 5.917

2.  BRCA1 Versus BRCA2 and PARP Inhibitors Efficacy in Solid Tumors:A Meta-Analysis of Randomized Controlled Trials.

Authors:  Shan Li; Li Tao; Haiyun Dai; Xue Gong; Yuguo Zhuo; Hui Xiang; Yueyang Zhao; Qing Gao; Liang Deng
Journal:  Front Oncol       Date:  2021-10-28       Impact factor: 6.244

3.  Circular RNA_0006014 promotes breast cancer progression through sponging miR-885-3p to regulate NTRK2 and PIK3/AKT pathway.

Authors:  Xiqian Zhou; Wei Jian; Qifeng Luo; Wenfang Zheng; Xiaochong Deng; Xuehui Wang; Oyungerel Borkhuu; Changle Ji; Dengfeng Li; Lin Fang
Journal:  Aging (Albany NY)       Date:  2022-04-05       Impact factor: 5.682

4.  Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer.

Authors:  Thais Baccili Cury Megid; Mateus C Barros-Filho; Janina Pontes Pisani; Maria Isabel Achatz
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

5.  BRCA1/Trp53 heterozygosity and replication stress drive esophageal cancer development in a mouse model.

Authors:  Ye He; Joshua Rivera; Miklos Diossy; Haohui Duan; Christian Bowman-Colin; Rachel Reed; Rebecca Jennings; Jesse Novak; Stevenson V Tran; Elizabeth F Cohen; David Szuts; Anita Giobbie-Hurder; Roderick T Bronson; Adam J Bass; Sabina Signoretti; Zoltan Szallasi; David M Livingston; Shailja Pathania
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-12       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.